MedPath

Effect of supplement on contrast sensitivity : a pilot study

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000033352
Lead Sponsor
TTC Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who have eye disease except refractive errors (e.g., Macular disease, optic media with advanced abnormalities) (2) Subject who are myopia over -6D (3) Subject who are daily corrected visual acuity less than 0.7 in both eyes (4) Subjects who are best corrected visual acuity of less than 1.0 (5)Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease) (6)Subjects who have history of surgical resection of the gastrointestinal tract (except for appendectomy) (7) Subjects who routinely take lutein or zeaxanthin containing supplement within the past year (8) Subjects who have history of smoking within the past year (9) Subjects who routinely take medicine (including eye drops) or health foods that may affect the results of this study (10) Subjects who may have symptoms of hay fever during study period (11) Subjects having possibilities for emerging allergy related to the study (12) Subjects who are in long-term treatment (including medication, hospitalization, diet and exercise therapy )or are planning to take treatment during study period (13) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (14) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on baseline examination (15) Subjects who intend to become pregnant or lactating (16) Subjects who have participated in other clinical study (17) Subjects who are judged as unsuitable by doctor for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath